Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Quest LaboratoriesNSE:QUESTLAB +8.08%44 Days Sales Outstanding is 96.04 as of Mar. 2026, which is 8% below its 10-year median of 104.55. GuruFocus rates NSE:QUESTLAB with a GF Score™ of 44/100. The stock has 5 warning signs investors should review. Among 949 Drug Manufacturers companies, Quest Laboratories ranks worse than 74.6% on this metric.
The historical rank and industry rank for Quest Laboratories's Days Sales Outstanding or its related term are showing as below:
NSE:QUESTLAB'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 95.62 Med: 104.55 Max: 128.18
Current: 104.84
During the past 6 years, Quest Laboratories's highest Days Sales Outstanding was 128.18. The lowest was 95.62. And the median was 104.55.
NSE:QUESTLAB's Days Sales Outstanding is ranked worse than 74.6% of 949
companies
in the Drug Manufacturers industry
Industry Median: 72
vs NSE:QUESTLAB: 104.84
Quest Laboratories's Days Sales Outstanding
increased
from Mar. 2025 (89.42) to Mar. 2026 (96.04).
Quest Laboratories (NSE:QUESTLAB) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Quest Laboratories Days Sales Outstanding Related Terms
Quest Laboratories Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Quest Laboratories's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:QUESTLAB vs LLY, JNJ, ABBV: Days Sales Outstanding Comparison
For the Drug Manufacturers - General subindustry, Quest Laboratories's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quest Laboratories Days Sales Outstanding vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Quest Laboratories's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Quest Laboratories's Days Sales Outstanding falls into.
Quest Laboratories Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Quest Laboratories (NSE:QUESTLAB) has a Days Sales Outstanding of 96.04 as of Mar. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Quest Laboratories and its competitors. This is near median its historical median of 104.55. Over the past decade, Quest Laboratories' Days Sales Outstanding has ranged from 95.62 to 128.18. According to the industry distribution chart, Quest Laboratories ranks #708 out of 949 companies in the Drug Manufacturers industry, placing it in the top 74.6%.
Is Quest Laboratories' Days Sales Outstanding too high?
Quest Laboratories' current Days Sales Outstanding of 96.04 is near median its 10-year median of 104.55. Over the past 10 years, this metric has ranged from a low of 95.62 to a high of 128.18. The Drug Manufacturers industry median Days Sales Outstanding is 72.00. Quest Laboratories' value of 96.04 is 33.4% above this industry median. Based on the distribution chart, Quest Laboratories ranks #708 out of 949 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Quest Laboratories has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Quest Laboratories' Days Sales Outstanding compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Quest Laboratories ranks #708 out of 949 companies for Days Sales Outstanding. This places Quest Laboratories in the lower half of its industry. The industry median Days Sales Outstanding is 72.00. Quest Laboratories' value of 96.04 is 33.4% above this benchmark. Historically, Quest Laboratories' own Days Sales Outstanding has ranged from 95.62 to 128.18 over the past decade. While the company's 10-year median is 104.55 vs. the industry median of 72.00, Quest Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Drug Manufacturers company?
The median Days Sales Outstanding among Drug Manufacturers companies is 72.00, based on 949 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Quest Laboratories's current Days Sales Outstanding of 96.04 is 33.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Quest Laboratories and its competitors. For the Drug Manufacturers industry, the median Days Sales Outstanding is 72.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quest Laboratories's current Days Sales Outstanding is 96.04, which is near median its own 10-year median of 104.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Laboratories stock overvalued right now?
Quest Laboratories (NSE:QUESTLAB) has a current Days Sales Outstanding of 96.04. The current Days Sales Outstanding is 96.04, which is near median its 10-year median of 104.55 and 33.4% above the Drug Manufacturers industry median of 72.00. Quest Laboratories' overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Quest Laboratories (NSE:QUESTLAB), the current Days Sales Outstanding is 96.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
44GF Score
Get the complete analysis for NSE:QUESTLAB
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QUESTLAB has been successfully added to your 
